A detailed history of Bnp Paribas transactions in Abb Vie Inc. stock. As of the latest transaction made, Bnp Paribas holds 46,060 shares of ABBV stock, worth $8.09 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
46,060
Previous 47,490 3.01%
Holding current value
$8.09 Million
Previous $8.15 Billion 11.65%
% of portfolio
0.38%
Previous 0.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $234,291 - $285,041
-1,430 Reduced 3.01%
46,060 $9.09 Billion
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $585,106 - $683,272
-3,780 Reduced 7.37%
47,490 $8.15 Billion
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $8.19 Million - $9.34 Million
51,270 New
51,270 $9.33 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bnp Paribas Portfolio

Follow Bnp Paribas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas, based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas with notifications on news.